Exploratory synthesis of solids is essential for the advancement of materials science but is also highly time- and resource-intensive. Here, we demonstrate an efficient strategy to explore solid-state synthesis of quaternary cesium chlorides in the search space of CsABCl ( = 2 or 3, A = Li, Na or K, and B = or -block metal), where the target compositions are selected from a pool of candidates based on computationally predicted stabilities and availability of viable precursor powders. Synthesizability of the targets is assessed by observing the evolution of starting phases upon heating under in situ synchrotron X-ray diffraction. Laboratory synthesis is attempted for promising targets, and resulting materials are characterized by powder X-ray and neutron diffraction and subsequent Rietveld refinement. We focus on how computational predictions can be bridged to experimental characterizations in exploratory synthesis and report on successful and failed synthesis attempts for compounds of type CsABCl, revealing underexplored variants including new polymorphs of CsLiCrCl and CsLiRuCl, and a new compound CsLiIrCl.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11528441 | PMC |
http://dx.doi.org/10.1021/jacs.4c10294 | DOI Listing |
Front Pharmacol
December 2024
Department of Cardiology, Hangzhou Hospital of Traditional Chinese Medicine, Hangzhou, Zhejiang, China.
Background: Bunge [Fabaceae; ] (AM), a traditional Chinese medicinal (TCM) botanical drug, has been used for centuries and is gaining growing recognition in medical research for its therapeutic potential. The currently accepted scientific name is Astragalus mongholicus Bunge, with Astragalus membranaceus Fisch. ex Bunge recognized as a taxonomic synonym.
View Article and Find Full Text PDFJAMA Netw Open
December 2024
School of Management, Shanxi Medical University, Taiyuan, China.
Importance: Blinding of individuals involved in randomized clinical trials (RCTs) can be used to protect against performance and biases, but discrepancies in the reporting of methodological features between registered protocols and subsequent trial publications may lead to inconsistencies, thereby reintroducing bias.
Objective: To investigate inconsistency in blinding as reported in trial registries and publications.
Data Sources: An exploratory dataset and a validation dataset were created.
Infect Drug Resist
December 2024
Department of Pediatric Endocrinology and Genetic Metabolism, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Institute for Pediatric Research, Shanghai, 200092, People's Republic of China.
Introduction: Growth hormone (GH) is crucial for immune system development and regulation, potentially benefiting COVID-19 outcomes. However, there are limited studies on the role of GH treatment in COVID-19 in children with short stature.
Methods: We conducted a survey study to evaluate the association between GH treatment and COVID-19 risk in short stature children aged 7 to 18 years.
J Eat Disord
December 2024
Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Objective: Night eating syndrome (NES) is an eating disorder characterized by evening hyperphagia. Despite having a prevalence comparable to some other eating disorders, NES remains sparsely investigated and poorly characterized. The present study examined the phenotypic and genetic associations for NES in the clinical Mass General Brigham Biobank.
View Article and Find Full Text PDFDalton Trans
December 2024
Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1-3, 119991 Moscow, Russia.
Two platinide plumbides, EuPtPb and SrPtPb, were discovered using high-temperature exploratory synthesis and flux-assisted crystal growth. Their crystal structures were determined from single-crystal X-ray diffraction. Both compounds crystallize in the orthorhombic system; EuPtPb belongs to the YRhSn structure type (2, = 4.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!